Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination

JAMA

Volumn 292, Issue 11, 2004, Pages 1317-1325

  Warner, Ellen ^a,e   Plewes, Donald B ^b   Hill, Kimberley A ^a   Causer, Petrina A ^a   Zubovits, Judit T ^a   Jong, Roberta A ^a   Cutrara, Margaret R ^a   DeBoer, Gerrit ^b   Yaffe, Martin J ^b   Messner, Sandra J ^b   Meschino, Wendy S ^d   Piron, Cameron A ^b   Narod, Steven A ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d NORTH YORK GENERAL HOSPITAL   (Canada)

^e DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRCA2 GENE; BREAST CANCER; BREAST EXAMINATION; BREAST IMAGING REPORTING AND DATA SYSTEM SCALE; CANADA; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER SUSCEPTIBILITY; DIAGNOSTIC ACCURACY; ECHOMAMMOGRAPHY; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC PREDISPOSITION; HETEROZYGOTE DETECTION; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOGENE; PRIORITY JOURNAL; SCORING SYSTEM; BIOPSY; BREAST TUMOR; COMPARATIVE STUDY; GENETICS; LABORATORY DIAGNOSIS; MIDDLE AGED; MUTATION; PHYSICAL EXAMINATION; SENSITIVITY AND SPECIFICITY; TUMOR SUPPRESSOR GENE;

ADULT; BIOPSY; BREAST NEOPLASMS; FALSE POSITIVE REACTIONS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MIDDLE AGED; MUTATION; PHYSICAL EXAMINATION; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, MAMMARY;

EID: 4544230001     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.292.11.1317     Document Type: Article

References (45)

1. Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 1998,62:676-689.
2. Daly MB, et al. The NCCN 2003 Genetic/Familial High-Risk Assessment Clinical Practice Guidelines in Oncology, version 1, 2003. Available at: http://www .nccn.org. Accessed August 2, 2004.
3. Burke W, Daly M, Garber J, et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer II BRCA1 and BRCA2: Cancer Genetics Studies Consortium. JAMA. 1997; 277:997-1003.
4. Breast Cancer Screening Monograph Working Group. IARC Handbooks of Cancer Prevention. Vol 7. Lyon, France: International Agency for Research on Cancers Press; 2002.
5. Brekelmans CTM, Seynaeve C, Bartels CC, et al. Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. J Clin Oncol. 2001;19:924-930.
6. Scheuer L, Kauff N, Robson M, et al. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol. 2002;20:1260-1268.
7. Weinreb JC, Newstead G. MR imaging of the breast. Radiology. 1995;196:593-610.
8. Stoutjeskijk MJ, Boetes C, Jager GJ, et al. Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Natl Cancer Inst. 2001;93:1095-1102.
9. Kuhl CK, Schmutzler RK, Leutner CC, et al. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology. 2000;215:267-279.
10. Morris EA, Liberman L, Ballon DJ, et al. MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol. 2003:181:619-626.
11. Kriege M, Brekelmans CTM, Boetes C, et al. MRI screening for breast cancer in women with familial or genetic predisposition. Fam Cancer. 2001:1:163-168.
12. Podo F, Sardanelli F, Canese R, et al. The Italian multicentre project on evaluation of MRI and other imaging modalities in early detection of mammary tumours in subjects at high genetic risk. J Exp Clin Cancer Res. 2002;21(suppl 3):115-124.
13. Kuhl CK, Schrading S, Leutner CC, et al. Surveillance of "high risk" women with proven or suspected familial (hereditary) breast cancer [abstract]. Proc Am Soc Clin Oncol. 2003:22:2.
14. Leach MO, Eeles RA, Turnbull LW, et al. The UK national study of magnetic resonance imaging for screening for breast cancer (MARIBS). J Exp Clin Cancer Res. 2002;21:107-114.
15. Tilanus-Linthorst MM, Obdeijn IM, Bartels KC, et al. First experience in screening women at high risk for breast cancer with MR imaging. Breast Cancer Res Treat. 2000:63:53-60.
16. Gordon PB. Ultrasound for breast screening and staging. Radiol Clin North Am. 2002;40:431-441.
17. Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast ultrasound and evaluation of factors that influence them. Radiology. 2002; 225:165-175.
18. Warner E, Plewes DB, Shumak RS, et al. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol 2001:19:3524-3531.
19. American College of Radiology (ACR) reporting system. In: Breast Imaging Reporting and Data System (BI-RADS). 2nd ed. Reston, Va: American College of Radiology; 1993:15-18.
20. Konyer NB, Ramsay EA, Bronskill MJ, Plewes DB. Comparison of MR imaging breast coils. Radiology. 2002:222:830-834.
21. Greenman RL, Lenkinski RE, Schnall MD. Bilateral imaging using separate interleaved 3D volumes and dynamically switched multiple receive coil arrays. Magn Reson Med. 1998;39:108-115.
22. Morris EA. Illustrated breast MR lexicon. Semin Roentgenol. 2001:36:238-249.
23. Kuhl CK, Mielcarek P, Klaschik S, et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology. 1999;211:101-110.
24. Nunes LW, Schnall MD, Siegelman ES, et al. Diagnostic performance characteristics of architectural features revealed by high spatial-resolution MR imaging of the breast. AJR Am J Roentgenol. 1997;169: 409-415.
25. Nunes LW, Schnall MD, Orel SG, et al. Breast MR imaging: interpretation model. Radiology. 1997;202: 833-841.
26. Nunes LW, Schnall MD, Orel SG, et al. Correlation of lesion appearance and histologic findings for the nodes of a breast MR imaging interpretation model. Radiographics. 1999;19:79-92.
27. Liberman L, Morris EA, Lee MJ, et al. Breast lesions detected on MR imaging: features and positive predictive value. AJR Am J Roentgenol. 2002;179: 171-178.
28. Mendelson EB, Berg WA, Merritt CR. Toward a standardized breast ultrasound lexicon, BI-RADS: ultrasound. Semin Roentgenol. 2001;36:217-225.
29. Stavros AT, Thickman D, Rapp CL, et al. Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology. 1995; 196:123-134.
30. Causer P, Piron C, Jong R, Curpen B, Hill K, Plewes D. A Medial/Lateral Access MRI Guided Breast Localization System: Proceedings of the Radiological Society of North America, Chicago, III, December 2003. Oak Brook, III: Radiological Society of North America; 2003.
31. Piron CA, ed. Hybrid Imaging Guidance System for Biopsy of Breast. Toronto, Ontario: Dept of Medical Biophysics, University of Toronto; 2001: 155.
32. Orel SG, Schnall MD, Newman RW, et al. MR imaging guided localization and biopsy of breast lesions: initial experience. Radiology. 1994;193:97-102.
33. Kuhl CK, Morakkabati N, Leutner CC, et al. MR imaging-guided large-core (14-gauge) needle biopsy of small lesions visible at breast MR imaging alone. Radiology. 2001;220:31-39.
34. Liberman L, Morris EA, Dershaw DD, et al. Fast MRI-guided vacuum-assisted breast biopsy: initial experience. AJR Am J Roentgenol. 2003;181:1283-1293.
35. Daniel BL, Birdwell RL, Butts K, et al. Freehand IMRI-guided large-gauge core needle biopsy: a new minimally invasive technique for diagnosis of enhancing breast lesions. J Magn Reson Imaging. 2001;13: 896-902.
36. Rosenberg RD, Hunt WC, Williamson MR, et al. Effects of age, breast density, ethnicity and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis. Radiology. 1998; 209:511-518.
37. Lakhani SR, Jacquemier J, Sloane JP, et al. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst. 1998;90:1138-1145.
38. Armes JE, Venter DJ. The pathology of inherited breast cancer. Pathology. 2002:34:309-314.
39. Sun CC, Lenoir G, Lynch H, Narod SA. In-situ breast cancer and BRCA1. Lancet. 1996;348:408.
40. Chang J, Yang WT, Choo HF. Mammography in Asian patients with BRCA1 mutations. Lancet. 1999; 353:2070-2071.
41. Coffin J, Chappuis PO, Wong N, Foulkes WD. Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Natl Cancer Inst. 2001;93:1754-1755.
42. Goss G, Sierra S. Current perspectives on radiation-induced breast cancer. J Clin Oncol. 1998:16:338-347.
43. Chen JJ, Silver D, Cantor S, et al. BRCA1, BRCA2, and Rad 51 operate in a common DNA damage response pathway. Cancer Res. 1999:59:17525-17565.
44. Narod S, Lubinski J. Roles of radiation dose, chemotherapy and hormonal factors in breast cancer following Hodgkins disease. J Natl Cancer Inst. 2003; 95:1552.
45. Warren R. Screening women at high risk of breast cancer on the basis of evidence. Eur J Radiol. 2001; 39:50-59.